Back to Invesco Ltd. Invesco Ltd.

ALNYALNY
28 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in ALNYLAM PHARMACEUTICALS INC

Yes. Invesco holds 3,754,318 shares of ALNY (Alnylam Pharmaceuticals), worth $1.1B, as of its Q2 2026 13F filing. It reduced the position by 320,802 shares (-7.9%) from Q1 2026. Invesco has held ALNY in every 13F on record since Q3 2019, 28 quarterly filings. ALNY is 0.1% of Invesco's reported 13F portfolio.

Current Value

$1.1B

Current Shares

3.8M

Total Value Change

+$1.1B

Total Shares Change

+3.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.8M
-7.9%
$1.1B0.1%$301.03
0
2026-Q1
Decreased
4.1M
-20.6%
$1.3B0.1%$330.87
0
2025-Q4
Increased
5.1M
+246.5%
$2B0.2%$397.65
62
2025-Q3
Increased
1.5M
+10.4%
$675.7M0.1%$456.00
42
2025-Q2
Increased
1.3M
+46.8%
$437.5M0.1%$326.09
43
2025-Q1
Increased
913,792
+63.6%
$246.7M0.0%$270.02
45
2024-Q4
Decreased
558,490
-19.7%
$131.4M0.0%$235.31
0
2024-Q3
Increased
695,868
+77.1%
$191.4M0.0%$275.03
46
2024-Q2
Increased
392,841
+120.3%
$95.5M0.0%$243.00
48
2024-Q1
Increased
178,313
+0.8%
$26.6M0.0%$149.45
29
2023-Q4
Decreased
176,860
-18.3%
$33.9M0.0%$191.41
0
2023-Q3
Decreased
216,569
-44.5%
$38.4M0.0%$177.10
0
2023-Q2
Increased
390,127
+6.2%
$74.1M0.0%$189.94
32
2023-Q1
Decreased
367,375
-45.2%
$73.6M0.0%$200.32
0
2022-Q4
Decreased
669,849
-9.2%
$159.2M0.0%$237.65
0
2022-Q3
Increased
737,830
+337.0%
$147.7M0.0%$200.16
49
2022-Q2
Decreased
168,831
-82.6%
$24.6M0.0%$145.85
0
2022-Q1
Increased
968,755
+8.8%
$158.2M0.0%$163.29
33
2021-Q4
Decreased
890,090
-15.6%
$150.9M0.0%$169.58
0
2021-Q3
Increased
1.1M
+5.2%
$199M0.1%$188.81
32
2021-Q2
Decreased
1M
-17.6%
$169.8M0.0%$169.52
0
2021-Q1
Decreased
1.2M
-4.9%
$171.7M0.0%$141.19
0
2020-Q4
Increased
1.3M
+16.8%
$166.1M0.0%$129.97
35
2020-Q3
Decreased
1.1M
-2.7%
$159.4M0.1%$145.60
0
2020-Q2
Increased
1.1M
+52.1%
$166.6M0.1%$148.11
42
2020-Q1
Increased
739,446
+27.9%
$80.5M0.0%$108.85
37
2019-Q4
Increased
578,130
+6.4%
$66.6M0.0%$115.17
32
2019-Q3
First report
543,482
-
$43.7M0.0%$80.42
0

Other major holders of ALNY: FMR LLC, Capital World Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used